James M. Youakim
Acadia Pharmaceuticals (United States)(US)
Publications by Year
Research Areas
Genetics and Neurodevelopmental Disorders, Family and Disability Support Research, Autism Spectrum Disorder Research, Child Nutrition and Feeding Issues, Schizophrenia research and treatment
Most-Cited Works
- → A normative study of the maintenance of wakefulness test (MWT)(1997)327 cited
- → Evaluation of the safety, tolerability, and efficacy of pimavanserin versus placebo in patients with Alzheimer's disease psychosis: a phase 2, randomised, placebo-controlled, double-blind study(2018)187 cited
- → Trofinetide for the treatment of Rett syndrome: a randomized phase 3 study(2023)178 cited
- → Efficacy and Safety of Adjunctive Brexpiprazole 2 mg in Major Depressive Disorder(2015)172 cited
- → Adjunctive Brexpiprazole 1 and 3 mg for Patients With Major Depressive Disorder Following Inadequate Response to Antidepressants(2015)161 cited
- → Trial of Pimavanserin in Dementia-Related Psychosis(2021)127 cited
- → Adjunctive Armodafinil for Major Depressive Episodes Associated With Bipolar I Disorder(2010)115 cited
- → Pimavanserin: Potential Treatment For Dementia-Related Psychosis(2018)83 cited
- → Identity Transformation in Medical Students(2009)74 cited
- → Posttraumatic Stress Disorder and Obstructive Sleep Apnea Syndrome(1998)72 cited